Traditional therapies for irritable bowel syndrome

An evidence-based appraisal

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Irritable bowel syndrome (IBS) is a common chronic disease that adversely effects quality of life and is associated with substantial direct and indirect health care costs. It is defined by a constellation of symptoms in conjunction with an alteration in bowel function and defecation, and its underlying pathophysiological basis remains unknown. Numerous therapies are available, but many relieve only one symptom of the syndrome, and their effectiveness has not been demonstrated with adequate evidence from high-quality studies. This article reviews the criteria for appropriate design of any treatment study as well as those criteria specific to studies of treatment for functional gastrointestinal diseases. Using these criteria, the author evaluates the published investigations of "traditional" IBS therapies (antidepressants, bulking agents/fiber, antispasmodics, antidiarrheals) and "alternative" IBS therapies (Chinese herbal supplements, peppermint oil, behavioral therapies). Based on this evaluation, the author concludes that the available evidence does not support the effectiveness of any of these treatments and, therefore, none of these treatments can be reliably recommended.

Original languageEnglish (US)
JournalReviews in Gastroenterological Disorders
Volume3
Issue numberSUPPL. 2
StatePublished - 2003

Fingerprint

Irritable Bowel Syndrome
Therapeutics
Antidiarrheals
Phytotherapy
Parasympatholytics
Defecation
Gastrointestinal Diseases
Health Care Costs
Antidepressive Agents
Chronic Disease
Quality of Life

Keywords

  • Antidiarrheals
  • Antispasmodics
  • Behavioral therapy
  • Irritable bowel syndrome
  • Study methodology

ASJC Scopus subject areas

  • Gastroenterology

Cite this

@article{6e15367c33824838bbbbcbaa1bb23762,
title = "Traditional therapies for irritable bowel syndrome: An evidence-based appraisal",
abstract = "Irritable bowel syndrome (IBS) is a common chronic disease that adversely effects quality of life and is associated with substantial direct and indirect health care costs. It is defined by a constellation of symptoms in conjunction with an alteration in bowel function and defecation, and its underlying pathophysiological basis remains unknown. Numerous therapies are available, but many relieve only one symptom of the syndrome, and their effectiveness has not been demonstrated with adequate evidence from high-quality studies. This article reviews the criteria for appropriate design of any treatment study as well as those criteria specific to studies of treatment for functional gastrointestinal diseases. Using these criteria, the author evaluates the published investigations of {"}traditional{"} IBS therapies (antidepressants, bulking agents/fiber, antispasmodics, antidiarrheals) and {"}alternative{"} IBS therapies (Chinese herbal supplements, peppermint oil, behavioral therapies). Based on this evaluation, the author concludes that the available evidence does not support the effectiveness of any of these treatments and, therefore, none of these treatments can be reliably recommended.",
keywords = "Antidiarrheals, Antispasmodics, Behavioral therapy, Irritable bowel syndrome, Study methodology",
author = "Fennerty, {M (Brian)}",
year = "2003",
language = "English (US)",
volume = "3",
journal = "Reviews in Gastroenterological Disorders",
issn = "1533-001X",
publisher = "MedReviews LLC",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Traditional therapies for irritable bowel syndrome

T2 - An evidence-based appraisal

AU - Fennerty, M (Brian)

PY - 2003

Y1 - 2003

N2 - Irritable bowel syndrome (IBS) is a common chronic disease that adversely effects quality of life and is associated with substantial direct and indirect health care costs. It is defined by a constellation of symptoms in conjunction with an alteration in bowel function and defecation, and its underlying pathophysiological basis remains unknown. Numerous therapies are available, but many relieve only one symptom of the syndrome, and their effectiveness has not been demonstrated with adequate evidence from high-quality studies. This article reviews the criteria for appropriate design of any treatment study as well as those criteria specific to studies of treatment for functional gastrointestinal diseases. Using these criteria, the author evaluates the published investigations of "traditional" IBS therapies (antidepressants, bulking agents/fiber, antispasmodics, antidiarrheals) and "alternative" IBS therapies (Chinese herbal supplements, peppermint oil, behavioral therapies). Based on this evaluation, the author concludes that the available evidence does not support the effectiveness of any of these treatments and, therefore, none of these treatments can be reliably recommended.

AB - Irritable bowel syndrome (IBS) is a common chronic disease that adversely effects quality of life and is associated with substantial direct and indirect health care costs. It is defined by a constellation of symptoms in conjunction with an alteration in bowel function and defecation, and its underlying pathophysiological basis remains unknown. Numerous therapies are available, but many relieve only one symptom of the syndrome, and their effectiveness has not been demonstrated with adequate evidence from high-quality studies. This article reviews the criteria for appropriate design of any treatment study as well as those criteria specific to studies of treatment for functional gastrointestinal diseases. Using these criteria, the author evaluates the published investigations of "traditional" IBS therapies (antidepressants, bulking agents/fiber, antispasmodics, antidiarrheals) and "alternative" IBS therapies (Chinese herbal supplements, peppermint oil, behavioral therapies). Based on this evaluation, the author concludes that the available evidence does not support the effectiveness of any of these treatments and, therefore, none of these treatments can be reliably recommended.

KW - Antidiarrheals

KW - Antispasmodics

KW - Behavioral therapy

KW - Irritable bowel syndrome

KW - Study methodology

UR - http://www.scopus.com/inward/record.url?scp=0038107303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038107303&partnerID=8YFLogxK

M3 - Article

VL - 3

JO - Reviews in Gastroenterological Disorders

JF - Reviews in Gastroenterological Disorders

SN - 1533-001X

IS - SUPPL. 2

ER -